Blue Star New Material: Announcement of Progress in Major Asset Restructuring.

The Board of Directors of the Company and all directors warrant that there are no false records, misleading statements or material omissions in the contents of this notice and bear individual and joint and several liability for the authenticity, accuracy and completeness of the contents8xX1, the basic situation of major asset restructuring and progress 8xX(i) Major asset restructuring plan 8xXThe Company's major asset restructuring plan consists of significant asset replacement, issuance of shares and payment of cash to purchase assets and the collection of matching funds: 8xX1, major asset replacement 8xCompany with its own assets and China Blue Star (Group) Co., Ltd(hereinafter referred to as "Blue Star Group" owned by the company8xXthe assets placed in this restructuring as follows: As of June 30, 2014, the Company deducts all assets and liabilities other than the assets sold and the $167,000.04 million other payables8xXthe assets placed in this restructuring are: Blue Star Group-owned Blue Star Andy Su Nutrition Group Limited ("Andy Su Group") 85% common equity (less 85% of Andesu Group 8xXshares of the Equity Intake After the Evaluation Date of the 85% cash dividend)8xX2, issue shares and pay cash to purchase assets 8xXthe difference in the price difference between the above-mentioned material asset replacement target assets shall be paid by the Company to the counterparty Blue Star Group in non-public issuance of shares and to pay cash purchases, of which the cash payment amount is 350 million yuan, the remainder is paid by issuing shares8xX3, issued shares to raise supporting funds 8xXin order to improve the integration performance of this transaction, listed companies intend to raise supporting funds from no more than 10 specific investors non-public issue of shares not more than 700 million yuan, not more than 25% of the transaction amount, of which no more than 350 million yuan for the payment of equity transfer consideration to blue star group, not more than 350 million yuan to supplement the listed company's liquidity, such as the collection of funds after deducting the funds required to pay the above-mentioned funds8xX(2) The progress of this reorganization 8xX1, June 3, 2015, the Company obtained the Ministry of Commerce issued the "Enterprise Overseas Investment Certificate" (Foreign Investment Certificate NoN1000201500276), the transaction has been the Ministry of Commerce on the foreign investment matters changes filed (filing number: commercial investment8xX2, June 10, 2015, the 5th meeting of the board of directors of listed companies to consider and pass the "on the adjustment of the company's major assets replacement and issuance of shares and the payment of cash to purchase assets and raise supporting funds and related transactions program" and other related bills8xX3, June 25, 2015, the Company obtained the National Development and Reform Commission issued by the "Project Filing Notice" (The Development and Reform Office of Foreign Investment Provisions No209), agreed to the Company's acquisition of Blue Star Andisu Nutrition Group Co., Ltdproject for the record8xX4, June 29, 2015, the Company was reviewed by the China Securities Regulatory Commission's Mergers and Acquisitions Review Committee on June 29, 2015 held the 54th working meeting of the 2015 meeting, the Company's major asset replacement and issuance of shares and the payment of cash to purchase assets and the collection of supporting funds and related transactions of major asset restructuring matters were unconditionally approved8xXII, Major Asset Restructuring, Proposed Assets Business 8xX Andesu Group is a global leader focused on the development, production and sale of animal nutrition additives, with more than 75 years of production and research and development experience, including methionine, vitamins, enzymepreparations and other animal nutrition additives With its extensive product portfolio, extensive sales platform and strong technical support team, and with its extensive product portfolio, and strong technical support team, the Andesu Group provides innovative animal nutrition additive solutions to more than 2,500 customers in more than 140 countries worldwide and establishes a global leadership position in key product lines: 8xX according to the European-based feed industry professional information website Info: Andesu Group is the world's leading producer of methionine, the world's second largest market share in 2014, and The Andesu Group is one of the two worldwide producers that can produce both solid and liquid methionine products, and Andesu Group is the first global company to establish a methionine production base in China 8xX methionine is one of the main products of the Andesu Group Due to the complexity of the chemically synthesized methionine production process, which requires a great deal of expertise and prior capital investment, the entire production process is strictly regulated by environmental protection and safe production, so only a few manufacturers around the world have the ability to produce methionine on a safe and stable scale Feedinfo estimates that the world's top three methionine producers had 84% of the market share in 2014, with Andesu Group the second largest in the world At the same time, as one of the two world producers that can produce both solid and liquid methionine products, Andesu Group offers more flexible methionine products in different forms according to different markets and customer needs 8xX China is one of the world's largest demand for methionine and one of the fastest growing markets, while Andesu Group is the first global company to set up a methionine production base in China Nanjing Andisu, with its full-process production process and competitive labor costs, is expected to become one of the largest and lowest-cost production bases of liquid methionine in the world, helping Andesu Group to seize the high-speed growth opportunities of China's methionine market demand, quickly respond to market changes, further enhance the competitive strength of and TheisU Group' competitive strength, and stabilize its leading market position 8xX The Main Financial Data for 2013 and 2014 are as follows: 8xX units: $8xX Project 2014 2013 8x operating income 992,015 .59 853,248.38 8xx operating profit 226,512.77 163,114.30 8x total profit 228,190.74 16 3,528.22 8xx Net profit 162,546.00 106,293.13 8xx net profit attributable to the owner of the parent company 162,545.79 106,2 92.28 8xx Methanol is the intermediate necessary for the production of methionine, which was discontinued in the second half of 2014 due to a leak at DuPont's plant in the United States, which produces methanol, which resulted in a global supply shortage of methionine, in 2014 In the second half of the year, the price of methionine products increased sharply As the world's first company to successfully integrate upstream and downstream production processes, and The Andesu Group can produce methanol on its own, and du Pont's shutdown has not affected it Due to the supply shortage of methionine in the second half of 2014, inventory levels in the industry are at historic lows and there was a strong replenishment demand in early 2015 As a result, the contract signings and sales expansion of the Andesu Group have been good so far, with orders, order prices and operating income exceeding forecasts At the same time, the European and Nanjing plants maintain good and efficient operation, raw material costs remain low These factors will provide a good guarantee of the Performance of the AndesU Group throughout the year 8xX this reorganization has been approved unconditionally by the China Securities Regulatory Commission's merger and reorganization review committee of listed companies, and is currently awaiting the final approval of the CSRC 8xX the Company will continue to fulfill its information disclosure obligations and promptly disclose the follow-up progress of this major asset restructuring matters, investors are kindly requested to pay attention to the Company's announcement 8xX hereby hereby 8xX Blue Star Chemical Materials Co., Ltd 8xX July 7, 2015 8xX the Board of Directors and all directors of this Announcement warrant that there are no false records, misleading statements or material omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of the contents 8xX 1, the basic situation of major asset restructuring and progress 8xX (i) Major asset restructuring plan 8xX The Company's major asset restructuring plan consists of significant asset replacement, issuance of shares and payment of cash to purchase assets and the collection of matching funds: 8xX 1, major asset replacement 8x Company with its own assets and China Blue Star (Group) Co., Ltd (hereinafter referred to as "Blue Star Group" owned by the company 8xX the assets placed in this restructuring as follows: As of June 30, 2014, the Company deducts all assets and liabilities other than the assets sold and the $167,000.04 million other payables 8xX the assets placed in this restructuring are: Blue Star Group-owned Blue Star Andy Su Nutrition Group Limited ("Andy Su Group") 85% common equity (less 85% of Andesu Group 8xX shares of the Equity Intake After the Evaluation Date of the 85% cash dividend) 8xX 2, issue shares and pay cash to purchase assets 8xX the difference in the price difference between the above-mentioned material asset replacement target assets shall be paid by the Company to the counterparty Blue Star Group in non-public issuance of shares and to pay cash purchases, of which the cash payment amount is 350 million yuan, the remainder is paid by issuing shares 8xX 3, issued shares to raise supporting funds 8xX in order to improve the integration performance of this transaction, listed companies intend to raise supporting funds from no more than 10 specific investors non-public issue of shares not more than 700 million yuan, not more than 25% of the transaction amount, of which no more than 350 million yuan for the payment of equity transfer consideration to blue star group, not more than 350 million yuan to supplement the listed company's liquidity, such as the collection of funds after deducting the funds required to pay the above-mentioned funds 8xX (2) The progress of this reorganization 8xX 1, June 3, 2015, the Company obtained the Ministry of Commerce issued the "Enterprise Overseas Investment Certificate" (Foreign Investment Certificate No N1000201500276), the transaction has been the Ministry of Commerce on the foreign investment matters changes filed (filing number: commercial investment 8xX 2, June 10, 2015, the 5th meeting of the board of directors of listed companies to consider and pass the "on the adjustment of the company's major assets replacement and issuance of shares and the payment of cash to purchase assets and raise supporting funds and related transactions program" and other related bills 8xX 3, June 25, 2015, the Company obtained the National Development and Reform Commission issued by the "Project Filing Notice" (The Development and Reform Office of Foreign Investment Provisions No 209), agreed to the Company's acquisition of Blue Star Andisu Nutrition Group Co., Ltd project for the record 8xX 4, June 29, 2015, the Company was reviewed by the China Securities Regulatory Commission's Mergers and Acquisitions Review Committee on June 29, 2015 held the 54th working meeting of the 2015 meeting, the Company's major asset replacement and issuance of shares and the payment of cash to purchase assets and the collection of supporting funds and related transactions of major asset restructuring matters were unconditionally approved 8xX II, Major Asset Restructuring, Proposed Assets Business 8xX Andesu Group is a global leader focused on the development, production and sale of animal nutrition additives, with more than 75 years of production and research and development experience, including methionine, vitamins, enzymepreparations and other animal nutrition additives With its extensive product portfolio, extensive sales platform and strong technical support team, and with its extensive product portfolio, and strong technical support team, the Andesu Group provides innovative animal nutrition additive solutions to more than 2,500 customers in more than 140 countries worldwide and establishes a global leadership position in key product lines: 8xX according to the European-based feed industry professional information website Info: Andesu Group is the world's leading producer of methionine, the world's second largest market share in 2014, and The Andesu Group is one of the two worldwide producers that can produce both solid and liquid methionine products, and Andesu Group is the first global company to establish a methionine production base in China 8xX methionine is one of the main products of the Andesu Group Due to the complexity of the chemically synthesized methionine production process, which requires a great deal of expertise and prior capital investment, the entire production process is strictly regulated by environmental protection and safe production, so only a few manufacturers around the world have the ability to produce methionine on a safe and stable scale Feedinfo estimates that the world's top three methionine producers had 84% of the market share in 2014, with Andesu Group the second largest in the world At the same time, as one of the two world producers that can produce both solid and liquid methionine products, Andesu Group offers more flexible methionine products in different forms according to different markets and customer needs 8xX China is one of the world's largest demand for methionine and one of the fastest growing markets, while Andesu Group is the first global company to set up a methionine production base in China Nanjing Andisu, with its full-process production process and competitive labor costs, is expected to become one of the largest and lowest-cost production bases of liquid methionine in the world, helping Andesu Group to seize the high-speed growth opportunities of China's methionine market demand, quickly respond to market changes, further enhance the competitive strength of and TheisU Group' competitive strength, and stabilize its leading market position 8xX Andesu Group's 2013 and 2014 Key Financial Data Are shown below: 8xX units: $8xX 2014 2013 8x operating income 992,015.59 8 53,248.38 8xx operating profit 226,512.77 163,114.30 8xx total profit 228,190.74 163,528.22